Who is sponsoring NCT04667832?

NCT04667832 is sponsored by Shiraz University of Medical Sciences.

What drugs are being tested in NCT04667832?

Interventions in NCT04667832: selective coronary artery angiography.

What condition does NCT04667832 study?

NCT04667832 studies Coronary Artery Disease.

Is NCT04667832 still recruiting?

NCT04667832 is currently completed. Last updated 22 December 2020.

Last reviewed 2020-12-22 · How we verify

NCT04667832

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ABI for Screening of Coronary Artery Disease

Completed Last updated 22 December 2020

What this trial tests

trial testing selective coronary artery angiography in Coronary Artery Disease in 4,207 participants. Completed in 1 October 2020.

Timeline

1 March 2019

Primary endpoint
1 September 2020

1 October 2020

Quick facts

Lead sponsor	Shiraz University of Medical Sciences
Status	Completed
Study type	OBSERVATIONAL
Enrollment	4,207
Start date	1 March 2019
Primary completion	1 September 2020
Estimated completion	1 October 2020
Sites	1 location across Iran

Drugs / interventions tested

selective coronary artery angiography

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Shiraz University of Medical Sciences

Who can join

Adults 30 to 88, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Large population cross sectional study between 2019-2020 for 4207 new patients that refer to professor Kojuri cardiovascular clinic in shiraz, Iran, was conducted. Patients were undergone selective coronary angiography from radial artery approach by an expert interventional cardiologist. ABI were measured for all patients. ABI ratio was compared with the results of coronary angiography for patients who underwent coronary angiography to measure specificity and sensitivity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Ankle-Brachial Index: A Simple and Inexpensive Screening Test for Coronary Artery Disease (ABI Goes Beyond the Foot) Running Title: ABI for Coronary Artery Disease Screening
Vafa RG, Zamiri B, Rahmani M, Parizi MjM, et al · · 2021 · DOI 10.21203/rs.3.rs-871459/v1

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Shiraz University of Medical Sciences trials

Trials by the same sponsor.

NCT07254221 — Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients · Phase 4 · not yet recruiting
NCT06509893 — Ticagrelore Alone Post PCI · Phase 4 · recruiting
NCT05876819 — Quality of Care and Welfare Services for Disabled Middle Older Adults in Iran Lebanon · enrolling by invitation
NCT06979427 — CTFFR and Prediction of Non-Significant CAD Lesions · NA · recruiting
NCT05711004 — Efficacy of Education Via Phone-based Text Messaging (SMS) on Patients With Uncontrolled Hypertension · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04667832 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shiraz University of Medical Sciences
Last refreshed: 22 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04667832.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing